These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2595750)

  • 1. Human scalp hair as evidence of individual dosage history of haloperidol: prospective study.
    Sato R; Uematsu T; Sato R; Yamaguchi S; Nakashima M
    Ther Drug Monit; 1989 Nov; 11(6):686-91. PubMed ID: 2595750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human scalp hair as evidence of individual dosage history of haloperidol: a possible linkage of haloperidol excretion into hair with hair pigment.
    Uematsu T; Sato R; Fujimori O; Nakashima M
    Arch Dermatol Res; 1990; 282(2):120-5. PubMed ID: 2353827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human scalp hair as evidence of individual dosage history of haloperidol: method and retrospective study.
    Uematsu T; Sato R; Suzuki K; Yamaguchi S; Nakashima M
    Eur J Clin Pharmacol; 1989; 37(3):239-44. PubMed ID: 2612538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history.
    Matsuno H; Uematsu T; Nakashima M
    Br J Clin Pharmacol; 1990 Feb; 29(2):187-94. PubMed ID: 2306410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human scalp hair as evidence of individual dosage history of haloperidol: longer-term follow-up study.
    Uematsu T; Sato R
    Ther Drug Monit; 1990 Nov; 12(6):582-3. PubMed ID: 2275006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorpromazine in human scalp hair as an index of dosage history: comparison with simultaneously measured haloperidol.
    Sato H; Uematsu T; Yamada K; Nakashima M
    Eur J Clin Pharmacol; 1993; 44(5):439-44. PubMed ID: 8359180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of a new fluoroquinolone derivative (Q-35) in human scalp hair as an index of drug exposure and as a time marker in hair.
    Uematsu T; Ohsawa Y; Mizuno A; Nakashima M
    Int J Legal Med; 1994; 106(5):237-43. PubMed ID: 8068569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of nicotine content of hair for assessing individual cigarette-smoking behavior.
    Mizuno A; Uematsu T; Oshima A; Nakamura M; Nakashima M
    Ther Drug Monit; 1993 Apr; 15(2):99-104. PubMed ID: 8503145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of temafloxacin in human scalp hair as an index of drug exposure.
    Uematsu T; Kondo K; Yano S; Yamaguchi T; Umemura K; Nakashima M
    J Pharm Sci; 1994 Jan; 83(1):42-5. PubMed ID: 8138908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using ofloxacin as a time marker in hair analysis for monitoring the dosage history of haloperidol.
    Nakano M; Uematsu T; Sato H; Kosuge K; Nishimoto M; Nakashima M
    Eur J Clin Pharmacol; 1994; 47(2):195-202. PubMed ID: 7859809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steady-state pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients: analysis of factors determining their concentrations in hair.
    Uematsu T; Matsuno H; Sato H; Hirayama H; Hasegawa K; Nakashima M
    J Pharm Sci; 1992 Oct; 81(10):1008-11. PubMed ID: 1432610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
    Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
    Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of flecainide in hair as an index of drug exposure.
    Takiguchi Y; Ishihara R; Kato R; Kamihara S; Yokota M; Uematsu T
    J Pharm Sci; 2001 Nov; 90(11):1891-6. PubMed ID: 11745746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The measurement of haloperidol and reduced haloperidol in neonatal hair as an index of placental transfer of maternal haloperidol.
    Uematsu T; Yamada K; Matsuno H; Nakashima M
    Ther Drug Monit; 1991 Mar; 13(2):183-7. PubMed ID: 2053128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of a method to analyze drugs in the hair and its application for determining patient compliance].
    Uematsu T
    Nihon Yakurigaku Zasshi; 1992 Dec; 100(6):475-83. PubMed ID: 1483601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.
    Wiles DH; McCreadie RG; Whitehead A
    Psychopharmacology (Berl); 1990; 101(2):274-81. PubMed ID: 2349370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
    Eklund K; Forsman A
    Clin Neuropharmacol; 1991; 14 Suppl 2():S7-12; discussion S12-5. PubMed ID: 1684310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bioavailability and pharmacokinetics of oral and depot intramuscular haloperidol in schizophrenic patients.
    Nayak RK; Doose DR; Nair NP
    J Clin Pharmacol; 1987 Feb; 27(2):144-50. PubMed ID: 3680566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.